baber/WOPTO huggingface dataset:
Patent NZ-598783-A (NZ)
Title: Use of opioid receptor antagonist for gastrointestinal tract disorders
Inventor: WOODWARD RICHARD M
IPC: A61K31/497
Filed: 2010-09-17
Abstract: 598783 Disclosed herein is a pharmaceutical composition comprising a compound of formula (I), 5-(2-methoxy-4-{ [2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl} -phenoxy)-pyrazine-2-carboxamide, and the use thereof in the treatment or prevention of opioid-induced constipation in a human, wherein the therapeutically effective amount is from about 0.1 mg to about 0.5 mg per day.
Patent NZ-599722-A (NZ)
Title: Amidoacetonitrile compounds having pesticidal activity
Inventor: GOEBEL THOMAS
IPC: C07C255/54
Filed: 2010-11-22
Abstract: 599722 Disclosed are compounds of the general formula (I), wherein the variable have the meanings as indicated in the disclosures, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites on warm-blooded animals. Examples of compounds of formula (I) are: N-[1-cyano-2-(5-cyano-2-{ 2-chloro-4-trifluoromethoxypheoxy} -phenoxy)-1-methylethyl]-4-trifluoromethoxybenzamide; or N-[1-cyano-2-(5-cyano-2-{ 2-chloro-4-trifluoromethoxypheoxy} -phenoxy)-1-methylethyl]-4-trifluromethoxysulfanylbenzamide; or N-[1-cyano-2-(5-cyano-2-{ 2-chloro-4-trifluoromethoxypheoxy} -phenoxy)-1-methylethyl]-4-trifluromethylsulfinylbenzamide; or N-[1-cyano-2-(5-cyano-2-{ 2-chloro-4-trifluoromethoxypheoxy} -phenoxy)-1-methylethyl]-4-trifluromethylsulfonylbenzamide.
Patent NZ-600542-A (NZ)
Title: Method for accumulation of polyhydroxyalkanoates in biomass with on-line monitoring for feed rate control and process termination
Inventor: WERKER ALAN GIDEON
IPC: C02F3/30
Filed: 2010-12-10
Abstract: 600542 Disclosed is a fed-batch method for producing high molecular weight polyhydroxyalkanoates (PHAs) in biomass, comprising: Directing biomass into a reactor having at least one first zone and at least one second zone; Intermittently and repeatedly stimulating the biomass respiration rate during a PHA accumulation process by exposing at least a fraction of biomass in at least one first zone to events of elevated substrate concentration; Monitoring and assessing, at least indirectly, the respiration rate of the biomass in the non-stimulating reactor zones; Controlling the frequency of biomass recirculation or rate of substrate addition; Retaining the biomass in the reactor; Harvesting PHA rich biomass form the reactor; Wherein the elevated substrate concentrations, achieved by mixing influent substrate with recirculated biomass and used to repeatedly stimulate the biomass respiration rate, is between 10 and 1000 mg- COD/L but preferably between 20 and 500 mg- COD/L.
Patent NZ-601224-A (NZ)
Title: Treatment with vb-201
Inventor: MENDEL ITZHAK
IPC: A61P29/00
Filed: 2011-01-05
Abstract: Unit dosage forms comprising between 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, or 80 mg 1-hexadecyl-2-(4’-carboxybutyl)-glycerol-3-phosphocholine (VB-201) and a pharmaceutically acceptable carrier, and formulated for oral administration, are disclosed herein, as well as treatment regimens comprising oral administration of VB-201 once or twice daily for treating an inflammatory disease or disorder selected from the group consisting of psoriasis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, atherosclerosis, an inflammation of a carotid artery, an inflammation of an aorta, colitis, ileitis, Crohn’s disease, chronic inflammatory intestinal disease, inflammatory bowel syndrome, inflammatory bowel disease, celiac disease, ulcerative colitis, an ulcer, a skin ulcer, a bed sore, a gastric ulcer, a peptic ulcer, a buccal ulcer, a nasopharyngeal ulcer, an esophageal ulcer, a duodenal ulcer, and a gastrointestinal ulcer.
Patent NZ-605873-A (NZ)
Title: Methods and compositions for cns delivery of arylsulfatase a
Inventor: SHAHROKH ZAHRA
IPC: A61P25/28
Filed: 2011-06-25
Abstract: Disclosed is a stable formulation comprising an arylsulfatase A (ASA) protein at a concentration at or greater than about 5 mg/ml, and wherein the formulation comprises no greater than 50 mM of phosphate.
Patent NZ-607222-A (NZ)
Title: Content server
Inventor: BARNETT TOM
IPC: G06Q30/00
Filed: 2011-08-08
Abstract: 607222 Disclosed is a content server (100) for serving content items for inclusion in a web page. The content server (100) is comprised of a web interface (101) arranged to receive requests for content items and to transmit content items in response to such requests. The content server (100) also includes a content store (103) arranged to store a plurality of content items, each content item having associated with it a desired number of impressions for a predetermined time period. The content server (100) also includes a serve log (104) arranged to store, for each content item, the most recent time which it was served by the content server (100). The content server (100) further includes a decision engine (102) arranged, in response to a request for content received by the web interface (101), to transmit a content item from the plurality of content of items via the web interface (101). The decision engine (102) is arranged to calculate, for each content item, a minimum time period for the content item based on its associated desired quantity of impressions and the predetermined time period. The decision engine (102) is further arranged to select the content item for transmission by the web interface (101) from amongst the content items for which the duration between the current time and the time stored in the serve log (104) exceeds the minimum time period calculated for the content item.
Patent NZ-613251-A (NZ)
Title: Method for determining uncollected energy
Inventor: BOHLEN WERNER HINRICH
IPC: F03D7/00
Filed: 2012-02-08
Abstract: The present invention relates to a method for creating a database comprising a plurality of correlation laws for determining the amount of uncollected energy on the basis of the consumed power of at least one reference wind power plant that was operated in a throttled or non-throttled manner. The method comprises the following steps: simultaneous detection (200) of the current output of the first wind power plant and of at least one reference wind power plant operating in the throttled or non-throttled manner; determining (202) in each case a correlation law, in particular a correlation factor, which establishes a relationship between the output of the first wind power plant and the output of the at least one reference wind power plant; and storing (204) the at least one correlation law or correlation factor as a function of at least one boundary condition.
Patent NZ-613716-A (NZ)
Title: Novel antibodies inhibiting c-met dimerization, and uses thereof
Inventor: GOETSCH LILIANE
IPC: A61P35/00
Filed: 2008-07-10
Abstract: Disclosed is an isolated antibody, or one of its functional divalent fragments capable of binding to the c-Met, wherein the antibody or functional divalent fragment comprises a heavy chain comprising CDR-H1, CDR-H2 and CDR-H3 comprising respectively the amino acid sequences GYTFTDYN, INPNNGGT, and ARGRYVGYYAMDY; and a light chain comprising CDR-L1, CDR-L2 and CDRL3 comprising respectively the amino acid sequence ENIYSN, AAT, and QHFWGPPYT.
Patent NZ-615090-A (NZ)
Title: Guanidine compound
Inventor: YOSHIHARA KOUSEI
IPC: C07D513/04
Filed: 2012-03-13
Abstract: The disclosure relates to a family of guanidine derivates of general formula (I), wherein the variables are defined in the specification. The disclosure also relates to pharmaceutical compositions comprising these compounds and their use in preventing and/or treating VAP-1-related diseases, including diabetic nephropathy or diabetic macular edema. Example compounds include: 2-fluoro-3-{ 4-[(trans-4-methoxycyclohexyl)carbonyl]piperazin-1-yl} benzylcarbamimidoylcarbamate, 2-fluoro-3-[4-(tetrahydro-2H-pyran-4-ylacetyl)piperazin-1-yl]benzylcarbamimidoylcarbamate, 3-[4-(ethylsulfonyl)piperazin-1-y1]-2-fluorobenzylcarbamimidoylcarbamate, 3-{ 4-[(1-acetylpiperidin-4-yl)oxy]piperidin-1-yl} -2-fluorobenzylcarbamimidoylcarbamate, 2-fluoro-3-{ 3-[1-(methoxyacetyppiperidin-4-yl]azetidin-l-y1)benzylcarbamimidoylcarbamate, 2-fluoro-3-{ 3-[1-(3-methoxypropanoyl)piperidin-4-yl]azetidin-l-yl} benzylcarbamimidoylcarbamate, 2-fluoro-3-{ 3-[1-(methylsulfonyl)piperidin-4-yl]azetidin-1-yl} benzylcarbamimidoylcarbamate.
Patent NZ-615698-A (NZ)
Title: An adapter for connecting a fuel cell and a fuel reservoir for an electroportable device, a cell and adapter assembly and the device
Inventor: RICORDI CHRISTIAN
IPC: H01M8/04
Filed: 2012-03-15
Abstract: An assembly of a fuel cell (2) for an electroportable device and of a connection adapter (3) for connecting the fuel cell and a fuel reservoir (1), the adapter being arranged for receiving a member (13) for supplying the cell and an ejection nosepiece (9) of the reservoir, the adapter comprising a valve (19) arranged for being actuated by the ejection nosepiece of the reservoir and switched from a plugging condition, before connection, to a fuel transmission condition, after connection. When connected, the fuel cell is permanently maintained under fuel supply.
Patent NZ-624259-A (NZ)
Title: Solar receiver with dual-exposure heat absorption panel
Inventor: WASYLUK DAVID T
IPC: F24S10/70
Filed: 2012-11-15
Abstract: A dual-exposure heat absorption panel is disclosed, which can be used in a solar receiver design. Generally, the heat absorption panel (200) includes a tube panel (210) through which a heat transfer fluid is flowed to absorb solar energy from heliostats that are focused on the tube panel. A structural support frame (300) surrounds the tube panel. A stiffener structure runs across the exposed faces of the tube panel. The headers and other support structures on the periphery are protected by use of a heat shield.
Patent NZ-627392-A (NZ)
Title: Load suspension and weighing system for a dialysis machine reservoir
Inventor: FULKERSON BARRY NEIL
IPC: G01G9/00
Filed: 2013-11-05
Abstract: A load suspension and weighing system for a removable reservoir unit of a portable dialysis machine includes a centrally located flexure assembly. The flexure assembly includes magnets (105, 135) and a number of flexure rings (115) which allow for movement of the magnets about a fixed circuit board (125). Sensors in the circuit board sense changes in the magnetic field as the magnets move in relation to the circuit board. The magnetic field changes produce a voltage output which is used by a processor to generate weight calculations. The top of the flexure assembly is attached to the interior of the dialysis machine. The entirety of the reservoir unit is suspended by a first internal frame that is attached to the bottom of the flexure assembly. Having a single flexure assembly positioned above the reservoir unit provides more accurate weight measurements while also preventing damage to the assembly from water spillage.
Patent NZ-700372-A (NZ)
Title: Ceftolozane antibiotic compositions
Inventor: TERRACIANO JOSEPH
IPC: C07D501/18
Filed: 2014-03-14
Abstract: This disclosure provides pharmaceutical compositions comprising ceftolozane, pharmaceutical compositions comprising ceftolozane and tazobactam, methods of preparing those compositions, and related methods and uses of these compositions. Specifically, ceftolozane is chemically unstable in certain lyophilized compositions, leading to the formation of degradation products. The methods of the present invention result in compositions having stabilized ceftolozane, thereby providing ceftolozane at a desired potency and with reduced impurities (degradation products). Stabilized compositions comprising ceftolozane and tazobactam can be prepared by lyophilizing ceftolozane in the absence of tazobactam and then blending the lyophilized ceftolozane with a solid tazobactam composition.
Patent NZ-714921-A (NZ)
Title: Magnet assemblies
Inventor: LESKOWITZ GARETT M
IPC: H01F7/02
Filed: 2014-06-02
Abstract: There are disclosed magnet arrays and methods for generating magnetic fields. In embodiments magnet arrays comprise a plurality of polyhedral magnets arranged in a lattice configuration wherein individual polyhedral magnets are placed with their centers substantially coinciding with a finite set of points defined by a lattice. The plurality of polyhedral magnets at least partly encloses a testing volume, and the magnet array has an associated magnetic field with a designated field direction v ̂, wherein the magnetization direction m ̂ of an individual polyhedral magnet located at a displacement vector r ⃗ from an origin point in the testing volume is determined by the formula: m ̂=((2(v ̂∙r ⃗ ) r ⃗-(r ⃗∙r ⃗ ) v ̂ ))⁄(r ⃗∙r ⃗ ). In embodiments the arrays are comprised in magnetic resonance machines. In embodiments the polyhedral magnets are truncated cubes or are rhombic dodecahedra.
Patent NZ-736553-A (NZ)
Title: Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
Inventor: SMITH ERNEST S
IPC: A61K39/395
Filed: 2014-09-11
Abstract: Discloses method of alleviating symptoms in a subject having a neurodegnerative disorder, comprising administering to that subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D). Neurodegenerative disorders may included Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Down syndrome, ataxia, Amyotrophic Lateral Sclerosis (ALS), Frontotemporal dementia (FTD), HIV-related cognitive impairment, CNS Lupus, mild cognitive impairment, or a combination thereof.
Patent NZ-741112-A (NZ)
Title: Heterocyclic compounds and uses thereof
Inventor: IBRAHIM PRABHA N
IPC: A61K31/506
Filed: 2016-09-19
Abstract: Provided herein are heterocyclic compounds of Formula (I), methods for their preparation and their intermediate compounds, also included are pharmaceutical compositions containing such compounds and their therapeutic uses.
Patent NZ-743178-A (NZ)
Title: Animal environmental and physiological monitoring system
Inventor: COCKROFT SCOTT
IPC: G06F3/0484
Filed: 2016-12-09
Abstract: Generally, an animal monitoring system including a bolus administered to reside in an animal operable to sense changes in one or more physiological parameters of the animal and generate and transmit encoded bolus sensor data to a tag affixed on the outside of the animal which operates to sense changes in one or more environmental parameters surrounding the animal and to generate encoded tag sensor data and to receive encoded bolus sensor data each of which can be analyzed by the tag or a remote data processor to generate environmental parameter values and physiological parameter values to assess an environmental or physiological condition of or about the animal.
Patent NZ-751168-A (NZ)
Title: Wave energy device with constricted tube and generator pod
Inventor: MOFFAT BRIAN LEE
IPC: F03B13/00
Filed: 2017-08-21
Abstract: A wave energy converter utilizes a flotation module that rises and falls with the passage of waves, a submerged tube containing a constriction which multiplies the speed of the water passing therethrough, a turbine (or other hydrokinetic apparatus) positioned so as to extract energy from the accelerated flow of water within and/or through the tube, and a submerged gas- or liquid-filled chamber housing one or more energy conversion components (e.g. generators, transformers, rectifiers, inverters). By providing a chamber in proximity to the turbine, generators can be placed in closer proximity to the turbine that turns them, and the shared shaft can be shorter than if the generators were placed in the buoy adjacent to the surface.
Patent NZ-760744-A (NZ)
Title: Fitment for a container neck
Inventor: ANTONELLI MARCO
IPC: B65D49/04
Filed: 2018-08-03
Abstract: The present invention relates to a closure for a container neck comprising a shell and a fitment. This arrangement provides a simple means of inserting and resiliently holding the fitment in the container neck. The fitment comprises a body and engagement means that extend radially outwardly from the body and releasably retain the fitment within the shell. During application of the closure to the container neck, the engagement means is forced from an extended condition into a retracted condition to release the fitment from the shell, and the fitment is inserted into the container neck into an operative position.
Patent NZ-773820-A (NZ)
Title: Methods and systems for diagnosing and treating health ailments
Inventor: SAMEC NICOLE
IPC: G02B6/26
Filed: 2016-03-16
Abstract: In order to diagnose, monitor, and treat health conditions and ailments, including ophthalmic as well as other conditions and ailments, a wearable augmented reality device is proposed and includes: an augmented reality head-mounted ophthalmic system comprising an augmented reality display platform configured to pass light from the world into an eye of a wearer wearing the head-mounted ophthalmic system, the eye having a retina; at least one light source configured to project light from the light source into the eye to form an image in the eye, the at least one light source configured to sweep the light from the light source across the retina of the eye to produce a reflex of the retina; and a sensor configured to measure a response of the retina to the swept light, wherein the head-mounted ophthalmic system is configured to perform retinoscopy to measure refractive error of the eye based upon the measured response of the retina to the swept light, wherein the display platform comprises a waveguide stack comprising a plurality of waveguides, wherein the plurality of waveguides are configured to output image light with different amounts of wavefront divergence corresponding to a plurality of depth planes, wherein one or more waveguides of the plurality of waveguides are configured to output the image light with a different amount of wavefront divergence than one or more other waveguides of the plurality of waveguides.
Patent PT-102029-A (PT)
Title: Preparation of anti-viral agents - comprises imidazole or pyrimidine precursors
Inventor: JACEWICZ VICTOR WITOLD
IPC: C07D473/32
Filed: 1997-07-18
Abstract: Preparation of the anti-viral agents penciclovir or famciclovir comprises: (a) forming a purine by closing an imidazole or pyrimidine ring; (b) reacting the purine with a precursor with a suitable side-chain in position 9; (c) converting the side-chain into (i) 4-hydroxy-3-hydroxymethylbutyl or (ii) 4-acetoxy-3-acetoxymethylbutyl; (d) converting the purine into guanine (using (i) or 2-aminopurine (using (ii)). The purine is of formula (I). R1 = halo, OH or a sulphonate; R2 = a side-chain in position 9; X1 = H, OH or precursor. Converting R1 into an amino gives the anti-viral agents.
Patent RU-94015248-A (RU)
Inventor: TAKHCHIDI KH P
IPC: A61F9/007
Filed: 1994-04-26
Abstract: FIELD: medicine. SUBSTANCE: method involves beginning dissection with forming a window in lens equator projection zone on the hyaloid membrane and then, when moving vitreotome along the posterior lens capsule, first of all dissecting areas of retrolental membrane the most distant from the posterior lens capsule. EFFECT: retained transparence of the lens.
Patent RU-94025022-A (RU)
Inventor: EPERIN A P
IPC: G21C19/32
Filed: 1994-07-13
Abstract: FIELD: nuclear power engineering. SUBSTANCE: process includes successive dressing of two partially damaged fuel assemblies during which each partially damaged fuel assembly is placed into individual two-section disengageable jacket. They are separated into two bundles of fuel elements. Damaged bundles of fuel elements are removed and mounting of fuel assembly is carried out from two undamaged bundles of fuel elements. In this case transportation of fuel elements during dressing and mounting is performed in sections of jacket. Transportation fixture is anchored at split of lower section of jacket prior to transportation of lower bundle of fuel elements. Dressing chamber incorporates crane, dressing shaft, cutting machine, clamping gear, manipulator and two-section disengageable jacket provided with clamping and centering members radially positioned in its upper section. Chamber is additionally fitted with second two-section split jacket and shaft for its placement, transportation fixture with aid for its fixation on split of lower section of jacket. Centering members are additionally displaced downwards along vertical relative to clamping members and are mounted for their synchronous movement under power lattice of bundle of fuel element of fuel assembly. EFFECT: enhanced reliability of process. 3 cl, 12 dwg
Patent RU-94026581-A (RU)
Inventor: KHOFER KHANS
IPC: E21C41/00
Filed: 1994-08-01
Abstract: FIELD: method for exploiting diamond pipe. SUBSTANCE: method for exploiting minerals deposits includes opening the deposit with wells and underground mining through mine shafts and crosscuts, destroying rock through the wells, delivering destroyed minerals through underground mine working. Exploitation of diamond-bearing pipe is carried out with panels in the form of ring cylinders. Panel comprises blocks installed along panel width. The block includes three digging breasts in the form of straight cylinders with their generatrices coming in contact with each other. Front of cleaning motion in a panel is carried out by digging minerals to adjoining blocks. Temporary solids are retained between spent panels. The solids are in the form of ring cylinders dug in the second order after partial or complete backfilling of worked off space of panels adjoining temporary solids. Preparation of panels to operation is carried out by ring connectors run on release horizon along axis dividing width of the panel by two. Preparation of digging blocks to clean digging is carried out by working from ring connectors of two breasts placed symmetrically about lengthwise axis of the connector. Pilot-well bottom is placed in roof of ring connectors and breasts. Minerals exploitation within margin of digging breasts is carried out by widening pilot-wells by rock destroying tool hung from drill casing in ring connector and breasts. Destroyed minerals are stacked in worked off space of digging breasts. Safety solid is retained, and bearing solid is formed under the base of the latter in the form of a cylinder. Diameter of the bearing solid exceeds diameter of pipe placed in the plane of solid base cross section. Summary height of the safety and bearing solids is at least equal to or exceeds thickness of flooded hoist rocks. Bearing solid is erected of ring cylinders formed by digging breasts with backfilling worked off space along direction from pipe boundary with hoist rocks towards its center. EFFECT: high efficiency. 4 cl, 7 dwg
Patent RU-94032812-A (RU)
Title: Cathode-luminescent light source
Inventor: SHEPETOV A P
IPC: H01J29/02
Filed: 1994-09-08
Abstract: FIELD: information displaying devices. SUBSTANCE: device has vacuum housing, controlled emitter of electrons and anode which is covered with current-conducting layer, for example, with aluminum, and over it with luminophor. Area of cur-conducting layer covers only part of anode. Another part of anode which is not covered with luminophor is shaped as grid which holes embraces islands of luminophor. Device may be used in design of middle-voltage cathode- luminescent light sources as well as aggregated very-large color TV screens and other information systems which use such light sources. EFFECT: increased efficiency.
Patent RU-94035297-A (RU)
Inventor: MAKHOVA E A
IPC: A23L29/231
Filed: 1994-09-21
Abstract: FIELD: food industry. SUBSTANCE: method involves preparing plant raw for hydrolysis, protopectin hydrolysis in the presence of hydrochloric acid at concentration 0.5-2% at hydromodulus = (1:5)-(1:7) at 75-78 C followed by washing with 70% ethanol firstly and then with 96% ethanol. Obtained product is used for confectionery article preparing. EFFECT: improved ecology properties, decreased sewage content, increased yield and enhanced quality of product.